• Company
• All-round prostate cancer treatment Xtandi with solid growth
• by Nov 18, 2021 05:55am

• Company
• Domestic approval of Tabrecta is imminent
• by Eo, Yun-Ho Nov 18, 2021 05:54am

• Policy
• MFDS reviews emergency use of Merck’s oral COVID-19 pill
• by Lee, Tak-Sun Nov 18, 2021 05:54am

• Policy
• Major bills have been piled up
• by Lee, Jeong-Hwan Nov 18, 2021 05:54am

• Product
• Expansion of non-face-to-face tx little by little
• by Nov 18, 2021 05:54am

• Policy
• Will impurities again in losartan trigger full recalls?
• by Lee, Tak-Sun Nov 17, 2021 05:45am

• Company
• Hugel's toxin has been approved for national lot release
• by Nho, Byung Chul Nov 17, 2021 05:44am

• Company
• Rinvoq combo rises as optimal option in rheumatoid arthritis
• by Nov 17, 2021 05:44am

• Company
• Exports of Botulinum drugs to the U.S. doubled
• by Kim, Jin-Gu Nov 17, 2021 05:44am

• Company
• Celltrion's COVID-19 tx is approved for sale in Europe
• by Chon, Seung-Hyun Nov 17, 2021 05:44am